Medical Journals

Microsomal Triglyceride Transfer Protein Activity is Not Required for the Initiation of Apolipoprotein B-containing Lipoprotein Assembly in Mca-rh7777 Cells.

Authors:
  • Dashti Nassrin
  • Manchekar Medha
  • Liu Yanwen
  • Sun Zhihuan
  • Segrest Jere P

From: Department of Medicine, University of Alabama at Birmingham Medical Center, Birmingham, Alabama 35294, USA. ndashti@uab.edu

The Journal of biological chemistry

  • Publish Date: Sep 2007
  • ISSN: 0021-9258
  • Volume: 282
  • Issue: 39
  • Pages: 28597-608
  • Medium: Print
  • Language: English
  • Citation (JAMA): Dashti Nassrin, Manchekar Medha, Liu Yanwen, et al. Microsomal Triglyceride Transfer Protein Activity is Not Required for the Initiation of Apolipoprotein B-containing Lipoprotein Assembly in Mca-rh7777 Cells.. J. Biol. Chem. Sep 2007;282:28597-608

Abstract

We previously demonstrated that the N-terminal 1000 amino acid residues of human apolipoprotein (apo) B (designated apoB:1000) are competent to fold into a three-sided lipovitellin-like lipid binding cavity to form the apoB “lipid pocket” without a structural requirement for microsomal triglyceride transfer protein (MTP). Our results established that this primordial apoB-containing particle is phospholipid-rich (Manchekar, M., Richardson, P. E., Forte, T. M., Datta, G., Segrest, J. P., and Dashti, N. (2004) J. Biol. Chem. 279, 39757-39766). In this study we have investigated the putative functional role of MTP in the initial lipidation of apoB:1000 in stable transformants of McA-RH7777 cells. Inhibition of MTP lipid transfer activity by 0.1 microm BMS-197636 and 5, 10, and 20 microm of BMS-200150 had no detectable effect on the synthesis, lipidation, and secretion of apoB:1000-containing particles. Under identical experimental conditions, the synthesis, lipidation, and secretion of endogenous apoB100-containing particles in HepG2 and parental untransfected McA-RH7777 cells were inhibited by 86-94%. BMS-200150 at 40 microm nearly abolished the secretion of endogenous apoB100-containing particles in HepG2 and parental McA-RH cells but caused only 15-20% inhibition in the secretion of apoB: 1000-containing particles. This modest decrease was attributable to the nonspecific effect of a high concentration of this compound on hepatic protein synthesis, as reflected in a similar (20-25%) reduction in albumin secretion. Suppression of MTP gene expression in stable transformants of McA-RH7777 cells by micro-interfering RNA led to 60-70% decrease in MTP mRNA and protein levels, but it had no detectable effect on the secretion of apoB:1000. Our results provide a compelling argument that the initial addition of phospholipids to apoB:1000 and initiation of apoB-containing lipoprotein assembly occur independently of MTP lipid transfer activity.

Mesh Headings (Keywords): Albumins, Animals, Apolipoprotein B-100, Binding Sites, Carrier Proteins, Cell Line, Tumor, Dose-Response Relationship, Drug, Egg Proteins, Humans, Indoles, Isoindoles, Liver, Phospholipids, Piperidines, Protein Biosynthesis, RNA, Small Interfering, Rats


Check for Full Text / PubMed Unique Identifier (PMID): 17690102


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.